These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 329623)

  • 21. [Epidemiological studies of increasing appearances of Proteus inconstans (Providencia stuartii) infections (author's transl)].
    Kopf PO; Freitag V; Caselitz FH; Kolbe S
    Immun Infekt; 1980; 8(3):96-100. PubMed ID: 7461700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Egg yolk reaction in Proteus.
    Legakis N; Leonardopoulos J; Papavassiliou J
    Boll Ist Sieroter Milan; 1974; 53(2):332-5. PubMed ID: 4609442
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of methods for typing Proteus mirabilis as applied in an epidemiological study of infections in a nursery for newborns.
    Burke JP; Adler JL; Finland M
    Antimicrob Agents Chemother (Bethesda); 1970; 10():328-31. PubMed ID: 4939738
    [No Abstract]   [Full Text] [Related]  

  • 24. [The problem of differentiation between Proteus bacteria strains by the demarcation line method].
    Sturdza SA
    Pathol Microbiol (Basel); 1970; 35(6):401-14. PubMed ID: 4923884
    [No Abstract]   [Full Text] [Related]  

  • 25. Serious nosocomial infection caused by Morganella morganii and Proteus mirabilis in a cardiac surgery unit.
    Williams EW; Hawkey PM; Penner JL; Senior BW; Barton LJ
    J Clin Microbiol; 1983 Jul; 18(1):5-9. PubMed ID: 6350354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the utilization of the Dienes phenomenon (demarcation line in Proteus) in bacteriological practice].
    Sturdza SA
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):503-17. PubMed ID: 4923820
    [No Abstract]   [Full Text] [Related]  

  • 27. Serotyping of Proteus mirabilis clinical strains based on lipopolysaccharide O-polysaccharide and core oligosaccharide structures.
    Kaca W; Glenska J; Lechowicz L; Grabowski S; Brauner A; Kwinkowski M
    Biochemistry (Mosc); 2011 Jul; 76(7):851-61. PubMed ID: 21999547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
    Saito R; Okugawa S; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K
    Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage typing of Proteus mirabilis, Proteus vulgaris, and Proteus morganii.
    Schmidt WC; Jeffries CD
    Appl Microbiol; 1974 Jan; 27(1):47-53. PubMed ID: 4589141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of epidemiological methods for differentiation of Proteus mirabilis.
    Kusek JW; Herman LG
    Am J Med Technol; 1981 Oct; 47(10):835-40. PubMed ID: 7036744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Swarming phenomenon of an aeromonas spec (author's transl)].
    Müller HE; Lenz W
    Zentralbl Bakteriol Orig A; 1975 May; 231(4):451-65. PubMed ID: 1101579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiological application of the Cradock-Watson system for Proteus mirabilis. Comparative study with another system of bacteriocin typing].
    Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández-Crehuet M; Rubio Peiró R; Piédrola Angulo G
    Rev Latinoam Microbiol; 1985; 27(2):77-81. PubMed ID: 3906814
    [No Abstract]   [Full Text] [Related]  

  • 33. First Isolation of carbon dioxide-dependent Proteus mirabilis from an uncomplicated cystitis patient with Sjögren's syndrome.
    Oana K; Yamaguchi M; Nagata M; Washino K; Akahane T; Takamatsu YU; Tsutsui C; Matsumoto T; Kawakami Y
    Jpn J Infect Dis; 2013; 66(3):241-4. PubMed ID: 23698488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
    Khan AU; Musharraf A
    Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separate O-grouping schemes for serotyping clinical isolates of Proteus vulgaris and Proteus mirabilis.
    Penner JL; Hennessy JN
    J Clin Microbiol; 1980 Sep; 12(3):304-9. PubMed ID: 7012166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ceftazidime and ciprofloxacin on biofilm formation in Proteus mirabilis rods.
    Kwiecińska-Piróg J; Bogiel T; Gospodarek E
    J Antibiot (Tokyo); 2013 Oct; 66(10):593-7. PubMed ID: 23801185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on retrograde Proteus mirabilis pyelonephritis in the rat. I. An experiment to obtain both pathologic sections and total number of bacteria from one kidney simultaneously (author's transl)].
    Takamoto H
    Nihon Hinyokika Gakkai Zasshi; 1981 Aug; 72(8):1006-10. PubMed ID: 7033614
    [No Abstract]   [Full Text] [Related]  

  • 39. [Determination of bacteriocinogenic types of strains of Proteus mirabilis].
    Józefowicz-Piatkowska H; Piatkowski K
    Med Dosw Mikrobiol; 1994; 46(3):151-60. PubMed ID: 7996932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.
    Yong D; Lim YS; Roh KH; Choi YS; Park DY; Yum JH; Kim JM; Lee K; Chong Y
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):237-9. PubMed ID: 16427241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.